Oncolytic Properties of a Mumps Virus Vaccine Strain in Human Melanoma Cell Lines


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Тек жазылушылар үшін

Аннотация

The oncolytic potential of the attenuated mumps virus (MV) vaccine strain Leningrad-3 (L-3) was evaluated in a panel of four human metastatic melanoma cell lines. The lines were shown to be susceptible and permissive to MV infection. Efficient MV replication led to death of melanoma cells, but the effect differed among the cell lines. Possible mechanisms mediating the selectivity of MV L-3 towards the cell lines were explored. Replicative and oncolytic activity of MV was found to depend on the expression pattern of type I interferon genes. None of the melanoma cell lines showed induction of expression of the total spectrum of genes required to inhibit virus replication. Based on the results, MV L-3 was assumed to be a promising oncolytic agent for human melanoma cells.

Негізгі сөздер

Авторлар туралы

Y. Ammour

Mechnikov Institute of Vaccines and Sera

Хат алмасуға жауапты Автор.
Email: yulia.ammour@yahoo.fr
Ресей, Moscow, 105064

O. Ryabaya

Blokhin Russian Cancer Research Center

Email: yulia.ammour@yahoo.fr
Ресей, Moscow, 115478

A. Milovanova

Mechnikov Institute of Vaccines and Sera

Email: yulia.ammour@yahoo.fr
Ресей, Moscow, 105064

A. Sidorov

Mechnikov Institute of Vaccines and Sera

Email: yulia.ammour@yahoo.fr
Ресей, Moscow, 105064

I. Shohin

OOO Center of Pharmaceutical Analytics

Email: yulia.ammour@yahoo.fr
Ресей, Moscow, 117246

V. Zverev

Mechnikov Institute of Vaccines and Sera

Email: yulia.ammour@yahoo.fr
Ресей, Moscow, 105064

T. Nasedkina

Engelhardt Institute of Molecular Biology

Email: yulia.ammour@yahoo.fr
Ресей, Moscow, 119991

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML

© Pleiades Publishing, Inc., 2018